Literature DB >> 18805580

JAK2--a new player in acute lymphoblastic leukaemia.

Charles G Mullighan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18805580     DOI： 10.1016/S0140-6736(08)61342-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity.

Authors:  Seiichi Odate; Veronica Veschi; Shuang Yan; Norris Lam; Richard Woessner; Carol J Thiele
Journal:  Clin Cancer Res       Date:  2016-10-19       Impact factor: 12.531

Review 2.  Understanding the biology of CRLF2-overexpressing acute lymphoblastic leukemia.

Authors:  Sarah K Tasian; Mignon L Loh
Journal:  Crit Rev Oncog       Date:  2011

3.  Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.

Authors:  Akinori Yoda; Yuka Yoda; Sabina Chiaretti; Michal Bar-Natan; Kartik Mani; Scott J Rodig; Nathan West; Yun Xiao; Jennifer R Brown; Constantine Mitsiades; Martin Sattler; Jeffrey L Kutok; Daniel J DeAngelo; Martha Wadleigh; Alfonso Piciocchi; Paola Dal Cin; James E Bradner; James D Griffin; Kenneth C Anderson; Richard M Stone; Jerome Ritz; Robin Foà; Jon C Aster; David A Frank; David M Weinstock
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

4.  Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancer.

Authors:  Musaffe Tuna; Marcel Smid; Dakai Zhu; John W M Martens; Christopher I Amos
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

5.  Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.

Authors:  Maribel Forero-Castro; Cristina Robledo; Rocío Benito; Irene Bodega-Mayor; Inmaculada Rapado; María Hernández-Sánchez; María Abáigar; Jesús Maria Hernández-Sánchez; Miguel Quijada-Álamo; José María Sánchez-Pina; Mónica Sala-Valdés; Fernanda Araujo-Silva; Alexander Kohlmann; José Luis Fuster; Maryam Arefi; Natalia de Las Heras; Susana Riesco; Juan N Rodríguez; Lourdes Hermosín; Jordi Ribera; Mireia Camos Guijosa; Manuel Ramírez; Cristina Díaz de Heredia Rubio; Eva Barragán; Joaquín Martínez; José M Ribera; Elena Fernández-Ruiz; Jesús-María Hernández-Rivas
Journal:  Br J Cancer       Date:  2017-05-30       Impact factor: 7.640

6.  Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo.

Authors:  Shuang Yan; Zhijie Li; Carol J Thiele
Journal:  Oncotarget       Date:  2013-03

Review 7.  New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update.

Authors:  Adrián Montaño; Maribel Forero-Castro; Darnel Marchena-Mendoza; Rocío Benito; Jesús María Hernández-Rivas
Journal:  Cancers (Basel)       Date:  2018-04-07       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.